Effect of sacral block combined with general anesthesia on postoperative recovery of TURP patients

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042619

Enrollment

Unknown

Registered

2021-01-24

Start date

2021-02-19

Completion date

Unknown

Last updated

2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate diseases

Interventions

experimental group A:general anesthesia

experimental groupe B:Ropivacaine sacral block combined with general anesthesia

experimental group C:Ropivacaine combined with dexmedetomidine for sacral block combined with general anesthesia.

Eligibility

Sex/Gender

Male

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) Male patients undergoing transurethral prostatectomy in urology department; (2) Aged > 18 years.

Exclusion criteria

Exclusion criteria: (1) Serious heart disease: myocardial infarction, heart failure or heart valve disease; (2) Allergic to drugs used in the experiment: such as those allergic to ropivacaine or dexmedetomidine; (3) Patients with spinal deformity; (4) There are contraindications of sacral block: abnormal coagulation function, intracranial hypertension, etc; (5) Patients who need ICU or assisted sedation after operation; (6) Patients refused to participate or could not cooperate.

Design outcomes

Primary

Measure	Time frame
Cystospasm score;	—

Secondary

Measure	Time frame
Recovery quality score;Times of postoperative rescue analgesia;	—

Countries

China

Contacts

Public ContactHongjie Xi

The Second Affiliated Hospital of Harbin Medical University

113038857@qq.com+86 18686719297

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026